Gladstone NOW: The Campaign Join Us on the Journey ✕
226 - 240 of 1461 Results Clear All
Hear about the “Strengths-Based Model of Neurodiversity” and how it can help neurodiverse individuals be successful in finding employment and in maximizing their professional potential
Communications Diversity
Virologist Sukrit Silas hopes to turn bacteria-killing viruses into new therapies that hold promise against even the most persistent superbugs.
News Release Profile Infectious Disease
Forbes—The world woke up 17 years ago to an astounding scientific breakthrough: a team of Japanese scientists led by Shinya Yamanaka—now an investigator at Gladstone—had reprogrammed skin cells to resemble an embryonic state. In this interview, Yamanaka shares fascinating insights about the backstory of his work and the doors it is starting to open for patients today.
Gladstone Experts Yamanaka Lab Stem Cells/iPSCs
ABC7 News—The most commonly reported symptom of long COVID is brain fog, which interferes with your ability to think clearly, remember things, and focus on a task. Senior Investigator Katerina Akassoglou explains the findings from her study that shed new light on what causes brain fog and the many other brain-related symptoms of long COVID and COVID-19.
Gladstone Experts COVID-19 Akassoglou Lab
The prize will be awarded annually to a Gladstone scientist who has made breakthrough discoveries in brain research; funds will help advance scientific discoveries from the lab to the clinic.
Awards News Release Alzheimer’s Disease Neurological Disease Huang Lab Aging Human Genetics
Longtime Gladstone supporter Darlene Hines reflects on her journey of learning, growth, and giving after her husband’s passing
Donor Stories
Gladstone scientists undertake a major effort to examine the diversity of retrons, bacterial defense systems that can be leveraged for precise gene editing
News Release Research (Publication) Data Science and Biotechnology Shipman Lab
San Francisco Business Times—The world’s first CRISPR-based drug that alters the genetic code is on the market. Thousands of other therapies using gene editing or stem cell technologies are in the works and offer potential cures. But how will society pay for these life-saving drugs? In this opinion piece, Gladstone President Deepak Srivastava shares his views on a new world of medical possibilities.
Gladstone Experts Srivastava Lab
Misha Zilberter discusses his Alzheimer's disease research, the importance of collaboration in science, and the advice he has for young scientists
Profile Alzheimer’s Disease Neurological Disease Huang Lab
Mucke, director of the Gladstone Institute of Neurological Disease, discusses what's next for Alzheimer’s research, the role of nonprofit research in developing new therapies, and why he's more hopeful than ever for a future where neurodegenerative diseases are fully treatable—and even preventable.
Alzheimer’s Disease Neurological Disease Mucke Lab Aging
University of San Francisco—Students in the Master’s in Biotechnology program at the University of San Francisco visited Gladstone to learn about industry-altering scientific breakthroughs and met with Benoit Bruneany, director of the Gladstone Institute of Cardiovascular Disease, and Stephen Freedman, vice president of corporate liaison and ventures.
Gladstone Experts
Genetic Engineering & Biotechnology News—Gladstone Investigator Seth Shipman and his team developed a new technology using retrons to engineer bacteria-fighting viruses known as phages, which could be used to kill antibiotic-resistant bacteria.
Gladstone Experts Shipman Lab
Scientists at Gladstone Institutes develop a streamlined and rapid way to engineer bacteria-fighting viruses known as phages
News Release Research (Publication) Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing
The $350 million Gladstone NOW campaign will raise funds to expand Gladstone’s footprint, hire hundreds of additional scientists, and seize emerging opportunities for high-impact biomedical research that can overcome disease.
Philanthropy Institutional News News Release
Tcheandjieu is one of 10 scholars nationwide selected as an emerging leader who's shaping the future of health and medicine.
Awards News Release Heart Failure Data Science and Biotechnology Tcheandjieu Lab AI Big Data
